MiNK Therapeutics shares surged 70% in pre-market trading after the company announced that its partner C-Further received up to $1.1 million in funding to advance pediatric cancer cell therapy research.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Continue fueling AI expenses! Oracle (ORCL.US) reportedly close to selling $10 billions in stocks at an 11% discount, priced at $116.
It is reported that Oracle is about to sell shares worth 10 billions USD at an 11% discount.
Synthetix Protocol DAO transfers 428,000 stolen SNX
Is cutting AI spending more beneficial? Bank of America gives a counterintuitive judgment: although “unpopular,” it may extend the economic cycle, and chip stocks could enjoy a longer profit runway.
Bank of America: Chip companies cutting capital expenditures may be “unpopular,” but it could extend the earnings cycle.
How will US stocks move after the midterm elections? Wolfe warns of a "wall of worry" about AI, while Morgan Stanley says the correction is nearing its end.
The "wall of worry" surrounding AI stands in the way, with Nvidia’s earnings report and oil prices becoming key variables.
Crypto prices
More
